11.27.24 -- Semantics Matter: DCTs And An Industry Decentralized

In this article, we address five key misconceptions about mobile research services, including concerns about inconsistent nurse assignments, privacy risks, and limited applications for complex protocols.

Explore what your organization should consider when selecting a digital health partner and monitoring solutions for your clinical trial.

Since life science professionals hail from diverse backgrounds, educations, and work experiences, different mentorship models serve their varied development needs and learning styles.

Expand your understanding of the cervical cancer (CC) clinical trial landscape, including current drug development funding, and the effect this disease has had on the world.

Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.

This interactive report features insights from Parexel experts dedicated to patient-focused drug development, striving to expedite the market arrival of more rare disease treatments.

Learn how Signant is helping to mitigate placebo responses and ensuring high-quality data to improve Prader-Willi syndrome (PWS) clinical trial success.

Alex Watt, Global Head for Biotech Integrated Laboratory Solutions, and Alan Wookey, Global Head of Companion Diagnostics, discuss how to manage both scientific and operational risk.

Get a free preliminary evaluation of your protocol design from a leading CRO in Eastern Europe.